br br Semaglutide, the current “it” drug for weight loss, that was initially approved for management of non-insulin requiring diabetes, type 2 diabetes, cuts and even eliminates the need for insulin injections by type 1 diabetics. This small University of Buffalo study was just published in the New England Journal of Medicine.br br Endocrinologists there studied 10 recently diagnosed diabetes type 1 patients. Each person was begun on injectable insulin both over the day and at mealtimes but was also given semaglutide. Over a 90 day period during which the semaglutide dose was increased, all were able to eliminate insulin for meals. Over 6 months, 7 of the 10 eliminated the need for any insulin. During the study, the mean HbA1c of the group fell from 11.7 to 5.7. Normal is less than 7br br These incredible findings, if confirmed in a larger, randomized, double-blinded study, could revolutionize the management of so-called insulin-dependent diabetes. Stay tuned.